Finance sources say the number could be as low as $14, with $15 seen as a best-case scenario.
Peter Georgiopoulos’s Gener8 was viewed as likely to take the deal even at that number to secure a listing on the New York Stock Exchange, and enable a team of private-equity backers led by Oaktree Capital Management to begin an exit from their investments.
